Author

Edwina Johnston

Institution: The Northern Ireland Cancer Centre

Observed institutions: Royal Marsden NHS Foundation Trust, Western Health and Social Care Trust, Royal Marsden Hospital, The Northern Ireland Cancer Centre

ORCID: 0000-0001-5344-7971

Observed ORCID: 0000-0001-5344-7971

OpenAlex ID: A5081687299

Neoadjuvant and Adjuvant Therapy Approaches to Gastric Cancer

2022 · Caroline Fong, Edwina Johnston, et al. · Current Treatment Options in Oncology · 60

Targeting FGFR2 Positive Gastroesophageal Cancer: Current and Clinical Developments

2022 · Anderley Gordon, Edwina Johnston, et al. · OncoTargets and Therapy · 38

124 Neo-adjuvant/peri-operative chemo-immunotherapy for resectable early stage Non-Small Cell Lung Cancer: a review of patients treated in Northern Ireland (NI) September 2023–November 2025

2026 · Edwina Johnston, Rand Al-bahlawan, et al. · Lung Cancer

Real-world outcomes for pembrolizumab in MSI-high (MSI-H) advanced colorectal cancer (CRC).

2026 · Ruba Ahmed Hamed, Edwina Johnston, et al. · Journal of Clinical Oncology

84 National Real World Study of Adjuvant Osimertinib in Resected EGFR Mutated Lung Cancer

2024 · Elghadi Ragd Sami, Pratheeshan Sabeshan, et al. · Lung Cancer

Works count: 5

Citation count: 98

H-index: 2

I10-index: 2